Kiromic BioPharma, Inc. is a clinical-stage biotechnology company focused on developing innovative immunotherapies and targeted therapies for cancer. With a unique multi-functional approach, Kiromic aims to revolutionize cancer treatment by harnessing the power of the immune system and personalized medicine.
